50 related articles for article (PubMed ID: 26164773)
1. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract][Full Text] [Related]
2. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.
Corbeau A; Heemsbergen WD; Kuipers SC; Godart J; Creutzberg CL; Nout RA; de Boer SM
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):127-142. PubMed ID: 37979708
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in the implementation of advanced brachytherapy programs for cervical cancer in the Philippines.
Bacorro W; Olonan BN; Co HC; Fineza-Dela Cruz AM
Asia Pac J Clin Oncol; 2024 Feb; 20(1):3-6. PubMed ID: 37743655
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
5. Variations and effects of bladder and rectal volume following uniform preparation procedure in cervical cancer: Five fractions of 6 Gy.
Ye BQ; Zhao CZ; Sun PF
J Contemp Brachytherapy; 2023 Apr; 15(2):123-129. PubMed ID: 37215620
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Toxicity Management in Patients with Locally Advanced Cervical Cancer following Exclusive Chemoradiation-A Nationwide Survey on Knowledge and Attitudes by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gynecology Study Group.
De Felice F; Vicenzi L; Macchia G; Vavassori A; Perrucci E; Cerrotta A; Lancellotta V; Meregalli S; Draghini L; Augurio A; De Sanctis V
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837584
[No Abstract] [Full Text] [Related]
7. Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients.
Guillemin F; Serre AA; Gassa F; Lorchel F; Sandt M; Lafay F; Charret J; Rannou C; Pommier P
J Contemp Brachytherapy; 2022 Jun; 14(3):248-252. PubMed ID: 36199995
[TBL] [Abstract][Full Text] [Related]
8. A single-institution review of image-guided brachytherapy for vaginal malignancies using customized molded applicators and interstitial needles.
Flower E; Zanjani S; Busuttil G; Sullivan E; Smith W; Tran K; Thwaites D; Chard J; Do V
J Contemp Brachytherapy; 2021 Dec; 13(6):663-669. PubMed ID: 35079253
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms.
Chen G; Han Y; Zhang H; Tu W; Zhang S
Front Oncol; 2021; 11():757973. PubMed ID: 34804953
[TBL] [Abstract][Full Text] [Related]
10. Effect of bladder volume on radiation doses to organs at risk and tumor in cervical cancer during image-guided adaptive brachytherapy and treatment outcome analysis.
Xu Z; Yang L; Ma L; Liu Q; Chang AT; Zhou Y; Zhou C; Kong FM; Chen L
Mol Clin Oncol; 2021 Dec; 15(6):258. PubMed ID: 34765192
[TBL] [Abstract][Full Text] [Related]
11. Quality Assurance in Modern Gynecological HDR-Brachytherapy (Interventional Radiotherapy): Clinical Considerations and Comments.
Soror T; Siebert FA; Lancellotta V; Placidi E; Fionda B; Tagliaferri L; Kovács G
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671552
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer.
Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G
J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197
[TBL] [Abstract][Full Text] [Related]
13. High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.
Vavassori A; Riva G; Spoto R; Lazzari R; Fodor C; Dicuonzo S; Francia CM; Augugliaro M; Facondo G; Cambria R; Comi S; Cattani F; Botta F; Bagnardi V; Rizzo S; Colombo N; Orecchia R; Jereczek-Fossa BA
J Contemp Brachytherapy; 2019 Dec; 11(6):516-526. PubMed ID: 31969909
[TBL] [Abstract][Full Text] [Related]
14. Development and assessment of 3D-printed individual applicators in gynecological MRI-guided brachytherapy.
Logar HBZ; Hudej R; Šegedin B
J Contemp Brachytherapy; 2019 Apr; 11(2):128-136. PubMed ID: 31139221
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.
Murakami N; Shima S; Kashihara T; Tselis N; Kato T; Takagawa Y; Masui K; Yoshida K; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
J Contemp Brachytherapy; 2019 Feb; 11(1):1-7. PubMed ID: 30911303
[TBL] [Abstract][Full Text] [Related]
16. Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy.
Bockel S; Escande A; Dumas I; Manea E; Morice P; Gouy S; Deutsch E; Haie-Meder C; Chargari C
J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30669569
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life.
Akbaba S; Oelmann-Avendano JT; Bostel T; Rief H; Nicolay NH; Debus J; Lindel K; Foerster R
Radiol Oncol; 2018 Sep; 52(3):320-328. PubMed ID: 30210042
[TBL] [Abstract][Full Text] [Related]
18. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.
Pötter R; Tanderup K; Kirisits C; de Leeuw A; Kirchheiner K; Nout R; Tan LT; Haie-Meder C; Mahantshetty U; Segedin B; Hoskin P; Bruheim K; Rai B; Huang F; Van Limbergen E; Schmid M; Nesvacil N; Sturdza A; Fokdal L; Jensen NBK; Georg D; Assenholt M; Seppenwoolde Y; Nomden C; Fortin I; Chopra S; van der Heide U; Rumpold T; Lindegaard JC; Jürgenliemk-Schulz I;
Clin Transl Radiat Oncol; 2018 Feb; 9():48-60. PubMed ID: 29594251
[TBL] [Abstract][Full Text] [Related]
19. Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
de Boer P; van de Schoot AJAJ; Westerveld H; Smit M; Buist MR; Bel A; Rasch CRN; Stalpers LJA
Strahlenther Onkol; 2018 Mar; 194(3):255-263. PubMed ID: 29101415
[TBL] [Abstract][Full Text] [Related]
20. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
